These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Electrophysiological interrelations of disopyramide with atropine]. González Maqueda I; García Fernández F; Martin Jadraque L; López Sendon JL; Coma Canella I Rev Esp Cardiol; 1979; 32(2):127-31. PubMed ID: 472418 [No Abstract] [Full Text] [Related]
7. [Electrophysiologic study of disopyramide]. Ponsonnaille J; Marcheix JC; Datchary J; Gras H Ann Cardiol Angeiol (Paris); 1979; 28(1):49-52. PubMed ID: 434759 [No Abstract] [Full Text] [Related]
8. The pharmacology of Norpace. Dean RR Angiology; 1975 Jan; 26(1 Pt 2):67-84. PubMed ID: 1115403 [No Abstract] [Full Text] [Related]
9. [Effects of disopyramide on the atrio-ventricular conduction in man. Preliminary results in 13 cases studied by means of recording bundle of His]. Lotto A; Graziina A; Rota M; Cavallaro GF; Greco EM Boll Soc Ital Cardiol; 1973; 18(10):934-6. PubMed ID: 4807027 [No Abstract] [Full Text] [Related]
10. Disopyramide (Norpace) for ventricular arrhythmias. Med Lett Drugs Ther; 1977 Dec; 19(25):101-2. PubMed ID: 593226 [No Abstract] [Full Text] [Related]
11. [Electrophysiological effects of disopyramide on the specialized cardiac conduction system in man (author's transl)]. Hombach V; Hespe I; Gil-Sanchez D; Freyland MD; Behrenbeck DW; Krüger H; Tauchert M; Hilger HH Z Kardiol; 1978 Aug; 67(8):527-33. PubMed ID: 695804 [No Abstract] [Full Text] [Related]
12. [Action of injected disopyramide on ventricular arrhythmias and atrioventricular conduction]. Vogel M; Desoutter P; Bellanger P; Motté G; Welti JJ Arch Mal Coeur Vaiss; 1976 Apr; 69(4):395-406. PubMed ID: 59581 [TBL] [Abstract][Full Text] [Related]
13. Electrophysiologic effects of the antiarrhythmic agent disopyramide phosphate. Befeler B; Castellanos A; Wells DE; Vagueiro MC; Yeh BK Am J Cardiol; 1975 Feb; 35(2):282-7. PubMed ID: 1119389 [TBL] [Abstract][Full Text] [Related]
14. [Effects of disopyramide on normal and pathological atrioventricular conduction]. Barnay C Ann Cardiol Angeiol (Paris); 1992 Oct; 41(8):449-53. PubMed ID: 1298185 [TBL] [Abstract][Full Text] [Related]
15. The electrophysiology of Norpace (Part I). Dreifus LS Angiology; 1975 Jan; 26(1 Pt 2):111-5. PubMed ID: 1115397 [No Abstract] [Full Text] [Related]
16. Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias. Heel RC; Brogden RN; Speight TM; Avery GS Drugs; 1978 May; 15(5):331-68. PubMed ID: 350555 [TBL] [Abstract][Full Text] [Related]
17. A seminar on Norpace (disopyramide phosphate) a new antiarrhythmic agent. Introductory remarks. Turiel SN; Smith WS Angiology; 1975 Jan; 26(1 Pt 2):65-6. PubMed ID: 1115402 [No Abstract] [Full Text] [Related]
18. [Anti-arrhythmia effect of disopyramide]. Olbermann M; Just H; Guckenbiehl H; Lang KF Verh Dtsch Ges Inn Med; 1975; 81():152-5. PubMed ID: 1229482 [No Abstract] [Full Text] [Related]